2 ms·
No, the CDC says Based on evidence from clinical trials in people 16 years and older, the Pfizer-BioNTech (COMIRNATY) vaccine was 95% effective at preventing l
by listenallyall 5y ago
No, the CDC says
Based on evidence from clinical trials in people 16 years and older, the Pfizer-BioNTech (COMIRNATY) vaccine was 95% effective at preventing laboratory-confirmed infection with the virus that causes COVID-19 in people who received two doses and had no evidence of being previously infected.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Pfizer-BioNTech.html https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different...
"Laboratory-confirmed infection". Not severe or hospitalized.
- jasonlaramburu 5y agoYou misrepresented the results of the original study as per above. The vaccine is 80% effective at preventing infection in frontline health workers (who are at elevated risk of exposure to COVID-19). It is 95% effective at preventing infection across the general population.